ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,088 filers reported holding ASTRAZENECA PLC in Q2 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $267,148 | +8.4% | 3,425 | -5.8% | 0.01% | 0.0% |
Q1 2024 | $246,368 | -0.4% | 3,636 | -1.0% | 0.01% | 0.0% |
Q4 2023 | $247,382 | -6.8% | 3,673 | -6.3% | 0.01% | -25.0% |
Q3 2023 | $265,333 | -20.3% | 3,918 | -15.8% | 0.01% | -20.0% |
Q2 2023 | $333,048 | +14.8% | 4,653 | +11.4% | 0.02% | +7.1% |
Q1 2023 | $290,028 | -4.6% | 4,178 | -24.7% | 0.01% | -22.2% |
Q3 2022 | $304,000 | -18.5% | 5,546 | -1.6% | 0.02% | -14.3% |
Q2 2022 | $373,000 | -22.5% | 5,639 | -22.3% | 0.02% | -8.7% |
Q1 2022 | $481,000 | +23.3% | 7,254 | +8.3% | 0.02% | +21.1% |
Q4 2021 | $390,000 | -5.1% | 6,697 | -2.2% | 0.02% | -17.4% |
Q3 2021 | $411,000 | +24.9% | 6,846 | +24.8% | 0.02% | +27.8% |
Q2 2021 | $329,000 | +32.1% | 5,487 | +9.4% | 0.02% | +20.0% |
Q1 2021 | $249,000 | -58.6% | 5,016 | -58.2% | 0.02% | -63.4% |
Q4 2020 | $601,000 | -70.3% | 12,012 | -67.4% | 0.04% | -73.2% |
Q3 2020 | $2,021,000 | +247.3% | 36,887 | +235.5% | 0.15% | +146.8% |
Q2 2020 | $582,000 | +94.6% | 10,996 | +64.2% | 0.06% | +40.9% |
Q1 2020 | $299,000 | +45.1% | 6,698 | +10.0% | 0.04% | +2.3% |
Q2 2018 | $206,000 | -5.9% | 6,091 | -1.2% | 0.04% | -12.2% |
Q4 2017 | $219,000 | – | 6,162 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |